MENU
+Compare
BDSX
Stock ticker: NASDAQ
AS OF
Sep 5, 04:59 PM (EDT)
Price
$0.44
Change
-$0.00 (-0.00%)
Capitalization
65M

BDSX Biodesix Forecast, Technical & Fundamental Analysis

Biodesix Inc is a diagnostic solutions company with a focus in lung disease... Show more

BDSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BDSX with price predictions
Sep 04, 2025

BDSX sees MACD Histogram just turned negative

BDSX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 29, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 47 cases where BDSX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BDSX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BDSX broke above its upper Bollinger Band on August 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 22, 2025. You may want to consider a long position or call options on BDSX as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BDSX advanced for three days, in of 219 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 160 cases where BDSX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BDSX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BDSX's P/B Ratio (54.348) is slightly higher than the industry average of (10.214). P/E Ratio (0.000) is within average values for comparable stocks, (138.370). BDSX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.672). Dividend Yield (0.000) settles around the average of (0.021) among similar stocks. P/S Ratio (0.809) is also within normal values, averaging (9.271).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BDSX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
BDSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BDSX is expected to report earnings to fall 23.25% to -6 cents per share on October 31

Biodesix BDSX Stock Earnings Reports
Q3'25
Est.
$-0.06
Q2'25
Missed
by $0.01
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.01
Q3'24
Est.
$-0.07
The last earnings report on August 07 showed earnings per share of -7 cents, missing the estimate of -7 cents. With 1.67M shares outstanding, the current market capitalization sits at 65.00M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
919 West Dillon Road
Phone
+1 303 417-0500
Employees
217
Web
https://www.biodesix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLRDF9.08N/A
N/A
Billerud AB
BSHI14.00N/A
N/A
Boss Holdings, Inc.
FAXRF13.50N/A
N/A
Fairfax Financial Holdings Ltd.
DLAKY8.67-0.22
-2.44%
Deutsche Lufthansa AG
TAKOF0.39-0.02
-4.15%
VOLATUS AEROSPACE INC.

BDSX and Stocks

Correlation & Price change

A.I.dvisor tells us that BDSX and ELMD have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BDSX and ELMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDSX
1D Price
Change %
BDSX100%
+5.05%
ELMD - BDSX
30%
Poorly correlated
+4.49%
KSRBF - BDSX
26%
Poorly correlated
N/A
RVTY - BDSX
26%
Poorly correlated
+2.81%
PLSE - BDSX
25%
Poorly correlated
+1.20%
VAPO - BDSX
24%
Poorly correlated
N/A
More